Milos Miljkovic

Milos Miljkovic

Company: Cartesian Therapeutics

Job title: CMO


Achieving Equitable Access to CAR-T & Other Cellular Therapy Through RNA Engineering 4:50 pm

Use of DNA-based cell therapy approaches is limited to academic medical centers in high-income countries due to high costs of manufacturing as well as the level of clinical care needed to manage toxicities RNA-engineered cellular therapy is less expensive to manufacture, less complex to prepare and administer and has less potential for significant short and…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.